TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11472321

Group type: EXPERIMENTAL
Intervention: Ecabet sodium 1 g b.d., amoxicillin 500 mg t.d.s. and clarithromycin 400 mg b.d. (EAC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg (o.m.) with the same antimicrobial agents (LAC)
Number of subjects: 120
Study: 9751449

Group type: EXPERIMENTAL
Intervention: Oestradiol alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oestradiol plus desogestrel
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Oestradiol valerate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 18
Study: 7842354

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1,000 mg/day for 2 weeks)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inert inositol tablets (control)
Number of subjects: 8
Study: 2896383

Group type: EXPERIMENTAL
Intervention: Trimoprostil (3 mg daily for 4 weeks)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Cimetidine (1 g daily for 4 weeks)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Trimoprostil
Number of subjects: 107

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 107
Study: 28325104

Group type: EXPERIMENTAL
Intervention: Hybrid-4 (4 hours/week for 8 weeks)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hybrid-8 (8 hours/week for 8 weeks)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Hybrid-4 and Hybrid-8
Number of subjects: 9
Study: 26456161

Group type: EXPERIMENTAL
Intervention: Resin Nano Ceramic (RNC) crowns bonded to zirconia abutments
Number of subjects: 50

Group type: COMPARATOR
Intervention: Reference standard (not explicitly mentioned as a control group)
Number of subjects: 50
Study: 24682975

Group type: EXPERIMENTAL
Intervention: DTC ads with placebo rates
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Mixed frame DTC ads
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Placebo/single frame ad
Number of subjects: 2000
Study: 23522365

Group type: EXPERIMENTAL
Intervention: Microwave sintering
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional sintering
Number of subjects: 32
Study: 19481275

Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Kinesitherapy (KT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Kinesitherapy + Electrical Stimulation (KT+ES)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 40
Study: 19033150

Group type: EXPERIMENTAL
Intervention: Web-based self-help intervention (Drinking Less) without therapist guidance.
Number of subjects: 261
Study: 16632138

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 7127

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 7127
Study: 12381251

Group type: EXPERIMENTAL
Intervention: Pantoprazole (20 mg once daily)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 307
Study: 10480346

Group type: EXPERIMENTAL
Intervention: Humanized antibody against HER2 (Herceptin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Humanized antibody against HER2 (Herceptin) combined with chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unspecified)
Number of subjects: 0
Study: 8548972

Group type: EXPERIMENTAL
Intervention: Topical 5% lignocaine ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard vaseline gauze pack
Number of subjects: 0
Study: 2331632

Group type: EXPERIMENTAL
Intervention: Congruent facial expression with verbal feedback
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Incongruent facial expression with verbal feedback
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Negative stimuli (face or verbal)
Number of subjects: 71
Study: 7442577

Group type: EXPERIMENTAL
Intervention: Videotaped lectures via CCTV
Number of subjects: 61

Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 61
Study: 31095949

Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve (Bif195)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 28718049

Group type: EXPERIMENTAL
Intervention: Inhaled insulin using a handheld, battery-operated, breath-actuated inhaler with aerosol generators producing 3-6 μm particle size distribution.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled insulin with inspiratory flow of 10 L/min guided by LED.
Number of subjects: 0
Study: 25497721

Group type: EXPERIMENTAL
Intervention: Low fibrinogen group (fibrinogen levels < 2 g/L or decreased by 25% or more)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Normal fibrinogen group (fibrinogen levels not meeting low criteria)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Clinical severity and hypofibrinogenemia
Number of subjects: 104
Study: 24176449

Group type: EXPERIMENTAL
Intervention: PEB + BMS
Number of subjects: 125

Group type: COMPARATOR
Intervention: DES
Number of subjects: 125
Study: 21379417

Group type: EXPERIMENTAL
Intervention: Artemether plus lumefantrine (A+L)
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin plus piperaquine (DHA+PQ)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Conventional treatment with chloroquine plus sulfadoxine plus pyrimethamine (CQ+S+P)
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: Artesunate plus sulfadoxine plus pyrimethamine (AS+S+P)
Number of subjects: 656
Study: 19910721

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATM) 40-100 mg per day, n = 14
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo, n = 13
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Atomoxetine (ATM)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study: 17908591

Group type: EXPERIMENTAL
Intervention: CAT-152 (100 microg in 100 microl phosphate buffer) administered via 4 subconjunctival injections before and after trabeculectomy and at 1 week post-surgery.
Number of subjects: 388

Group type: COMPARATOR
Intervention: Placebo administered via 4 injections before and after trabeculectomy and at 1 week post-surgery.
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: CAT-152
Number of subjects: 388
Study: 14961887

Group type: EXPERIMENTAL
Intervention: Duloxetine 40 mg BD for 12 weeks
Number of subjects: 494

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 494
Study: 11311926

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MP)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 9241341

Group type: EXPERIMENTAL
Intervention: 2-Chloroprocaine (2-CP)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 2-Chloroprocaine (2-CP) + epinephrine (Epi, 5 micrograms.ml-1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: 2% lidocaine (Lido) + epinephrine (Epi)
Number of subjects: 42
Study: 8363422

Group type: EXPERIMENTAL
Intervention: APSAC (30 mg i.v. over 5 minutes)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: rt-PA (10 mg bolus + 5000 IU of heparin as a bolus, followed by 90 mg rt-PA over 3 hours)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Streptokinase (1.5 MU in 1 hour)
Number of subjects: 270
Study: 3097293

Group type: EXPERIMENTAL
Intervention: L-carnitine (50 mumol/kg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31724913

Group type: EXPERIMENTAL
Intervention: High source credibility
Number of subjects: 207

Group type: COMPARATOR
Intervention: Low source credibility
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Negatively framed messages
Number of subjects: 207

Group type: COMPARATOR
Intervention: Positively framed messages
Number of subjects: 207
Study: 31378383

Group type: EXPERIMENTAL
Intervention: Paracetamol (1 g)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Combination (1 g paracetamol, 400 mg ibuprofen, 60 mg codeine)
Number of subjects: 119
Study: 28331155

Group type: EXPERIMENTAL
Intervention: Celecoxib monotherapy (NSAID group)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Stretching exercises (exercise group)
Number of subjects: 33
Study: 26005933

Group type: EXPERIMENTAL
Intervention: Tuning in to Teens (TINT) program
Number of subjects: 449
Study: 24024705

Group type: EXPERIMENTAL
Intervention: ERCP-first
Number of subjects: 257

Group type: COMPARATOR
Intervention: MRCP-first
Number of subjects: 257
Study: 21598207

Group type: EXPERIMENTAL
Intervention: Occupational group therapy, performed regularly 6 days a week
Number of subjects: 56

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 56
Study: 19546766

Group type: EXPERIMENTAL
Intervention: Sumatriptan 85 mg and naproxen sodium 500 mg (sumatriptan-naproxen)
Number of subjects: 621
Study: 17008408

Group type: EXPERIMENTAL
Intervention: Polymorphisms in PDE9A and PDE11A
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Polymorphisms in PDE1A and PDE11A
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: PDE11A haplotype GAACC
Number of subjects: 284
Study: 15281544

Group type: EXPERIMENTAL
Intervention: Lightwand-guided intubation in supine position
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lightwand-guided intubation in left lateral position
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lightwand-guided intubation in right lateral position
Number of subjects: 120
Study: 10619939

Group type: EXPERIMENTAL
Intervention: Lithoclast
Number of subjects: 46

Group type: COMPARATOR
Intervention: Electrokinetic Lithotripter (EKL)
Number of subjects: 46
Study: 9184950

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (50 micrograms every 4 hours up to 600 micrograms)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Intravenous oxytocin (standard protocol by continuous infusion)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol
Number of subjects: 123

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 123
Study: 1587572

Group type: EXPERIMENTAL
Intervention: Open reduction and coracoclavicular screw fixation (20 patients)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-operative management (28 patients)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Open reduction and coracoclavicular screw fixation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Late salvage surgery (6 patients)
Number of subjects: 48
Study: 4091236

Group type: EXPERIMENTAL
Intervention: Histamine equivalent prick (HEP) standard allergen extracts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Protein nitrogen units (PNU) standard allergen extracts
Number of subjects: 0
Study: 3297376

Group type: EXPERIMENTAL
Intervention: Alizapride (AZP) 2 mg/kg for 4 doses
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Alizapride (AZP) 2 mg/kg for 4 doses + Dexamethasone (DXM) 8 mg for five doses
Number of subjects: 29

Group type: COMPARATOR
Intervention: Metoclopramide (MCP) 1 mg/kg for four doses + Dexamethasone (DXM) 8 mg for five doses
Number of subjects: 29
Study: 31135965

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 28490227

Group type: EXPERIMENTAL
Intervention: Numeric with spinners
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Numeric with icon arrays
Number of subjects: 151

Group type: COMPARATOR
Intervention: Numeric only
Number of subjects: 151
Study: 25422488

Group type: EXPERIMENTAL
Intervention: Doxorubicin-cyclophosphamide administered continuously
Number of subjects: 3250

Group type: EXPERIMENTAL
Intervention: Paclitaxel administered once per week
Number of subjects: 3250

Group type: COMPARATOR
Intervention: Doxorubicin-cyclophosphamide administered once every 2 weeks
Number of subjects: 3250

Group type: COMPARATOR
Intervention: Paclitaxel administered once every 2 weeks
Number of subjects: 3250
Study: 22235762

Group type: EXPERIMENTAL
Intervention: Electrical mallet (magnetic mallet, Meta‐Ergonomica)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Hand mallet
Number of subjects: 36
Study: 21515996

Group type: EXPERIMENTAL
Intervention: Integrated care service (n=36) including physical therapy, acupuncture, western medicines or herbal medicines
Number of subjects: 85

Group type: COMPARATOR
Intervention: Western care (n=49) including physical therapy or western medicines
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Integrated care service (n=36)
Number of subjects: 85
Study: 19630713

Group type: EXPERIMENTAL
Intervention: Pharmacological aids (e.g., nicotine replacement therapy, bupropion)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Behaviorally- or psychosocially-based interventions
Number of subjects: 0
Study: 16963397

Group type: EXPERIMENTAL
Intervention: Long-term follow-up after completion of therapy
Number of subjects: 32
Study: 12858323

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 53

Group type: COMPARATOR
Intervention: Zaleplon 10 mg
Number of subjects: 53
Study: 10840912

Group type: EXPERIMENTAL
Intervention: Picture (with no phrase)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Phrase (with no picture)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Picture and phrase
Number of subjects: 129

Group type: COMPARATOR
Intervention: No picture and no phrase
Number of subjects: 129
Study: 9589359

Group type: EXPERIMENTAL
Intervention: Retinamide II (RII) suppositories, 10 mg QD, given intravaginally for 6 months (each course lasting 3 months)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Retinamide II (RII) suppository intravaginally, once daily for 50 days in two courses
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo, once daily for 50 days in two courses
Number of subjects: 27
Study: 8494776

Group type: EXPERIMENTAL
Intervention: Continuous vibration at 100 Hz with 100 shocks per second at 2.5, 5, or 10 ms‐2 rms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repetitive shocks at 5 shocks per second at 2.5, 5, or 10 ms‐2 rms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition with no vibration
Number of subjects: 0
Study: 3915206

Group type: EXPERIMENTAL
Intervention: Middle ear irrigation during tympanostomy tube insertion
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (no irrigation)
Number of subjects: 220
Study: 30880777

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg/day) for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: No supplementation (control)
Number of subjects: 20
Study: 29100706

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IIV3)
Number of subjects: 4081

Group type: COMPARATOR
Intervention: Inactivated polio vaccine (IPV)
Number of subjects: 4081
Study: 25186452

Group type: EXPERIMENTAL
Intervention: Cutanplast
Number of subjects: 100

Group type: COMPARATOR
Intervention: Spongostan
Number of subjects: 100
Study: 23829417

Group type: EXPERIMENTAL
Intervention: Supported telemetric monitoring of glycemic control and blood pressure
Number of subjects: 320

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 320
Study: 21098648

Group type: EXPERIMENTAL
Intervention: Phytoestrogens intake (isoflavonoids/lignans/coumestrol)
Number of subjects: 47140

Group type: EXPERIMENTAL
Intervention: Fiber intake (vegetable/cereal)
Number of subjects: 47140

Group type: EXPERIMENTAL
Intervention: Specific food items rich in phytoestrogens (berries, nuts, beans/soy, crisp or whole-grain bread)
Number of subjects: 47140

Group type: EXPERIMENTAL
Intervention: Fiber and coumestrol intake
Number of subjects: 47140
Study: 19375954

Group type: EXPERIMENTAL
Intervention: Full preparation (2-L polyethylene glycol solution with 20 mL of sodium diatrizoate)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Minimum preparation (45 mL of sodium diatrizoate and 10 mL of sodium picosulfate solution)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Full preparation
Number of subjects: 101

Group type: COMPARATOR
Intervention: Minimum preparation
Number of subjects: 101
Study: 17552046

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15466736

Group type: EXPERIMENTAL
Intervention: Deep-dish rotating platform
Number of subjects: 50

Group type: COMPARATOR
Intervention: Anterior-posterior gliding mobile bearing
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 11841770

Group type: COMPARATOR
Intervention: No microorganism (no-group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Pseudomonas (Ps-group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Other microorganisms (another-group)
Number of subjects: 70
Study: 10682564

Group type: EXPERIMENTAL
Intervention: Fraxiparine (0.4 ml hypodermically injected per day for 7 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 8583438

Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate (Fleet PhosphoSoda)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Polyethylene glycol electrolyte (PEG) solution (GoLYTELY)
Number of subjects: 79
Study: 2243264

Group type: EXPERIMENTAL
Intervention: Teacher-directed health education program
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Learner-paced health education program
Number of subjects: 78
Study: 632455

Group type: EXPERIMENTAL
Intervention: .3 mg/kg of Ritalin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Behavior modification
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ritalin and Behavior modification
Number of subjects: 20
Study: 31122890

Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Lights (MTL)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Warning symbol
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Health Star Rating system (HSR)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Reference Intakes (RIs)
Number of subjects: 1000
Study: 31462288

Group type: EXPERIMENTAL
Intervention: First-line chemotherapy regimens (specific regimens not detailed)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: First-line chemotherapy for patients with weight loss ≥10% at baseline
Number of subjects: 145
Study: 28075381

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs (480 mg DHA and 720 mg EPA per day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs
Number of subjects: 86
Study: 26604725

Group type: EXPERIMENTAL
Intervention: Rose hip powder (Hyben Vital)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Astaxanthin
Number of subjects: 34
Study: 23623474

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive (COC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Etonogestrel-releasing implant
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Copper intrauterine device (IUD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No contraceptive use (control group)
Number of subjects: 40
Study: 20430565

Group type: EXPERIMENTAL
Intervention: Counseling programs with advice about nicotine replacement therapy (and additional bupropion‐SR in one of the programs)
Number of subjects: 667

Group type: COMPARATOR
Intervention: Usual care (periodic regular check‐ups and COPD information)
Number of subjects: 667
Study: 19644802

Group type: EXPERIMENTAL
Intervention: Etofibrate 1000 mg/day for up to 12 months
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 17955657

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study: 15450547

Group type: EXPERIMENTAL
Intervention: Emergency contraception (EC) knowledge and experience
Number of subjects: 10918

Group type: EXPERIMENTAL
Intervention: Emergency contraception (EC) use
Number of subjects: 10918

Group type: EXPERIMENTAL
Intervention: Correct knowledge of EC
Number of subjects: 10918

Group type: EXPERIMENTAL
Intervention: History of EC use
Number of subjects: 10918
Study: 12003484

Group type: EXPERIMENTAL
Intervention: Powerclean toothbrush
Number of subjects: 78

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 78
Study: 17294628

Group type: EXPERIMENTAL
Intervention: Fluoride-glass sealant
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Delton Plus
Number of subjects: 25

Group type: COMPARATOR
Intervention: Delton (conventional sealant)
Number of subjects: 25
Study: 8092223

Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 3383611

Group type: EXPERIMENTAL
Intervention: Controlled-release naproxen (750 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard naproxen (750 mg)
Number of subjects: 12
Study: 29804360

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 474

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 474

Group type: COMPARATOR
Intervention: Dietary control alone
Number of subjects: 474
Study: 28243834

Group type: EXPERIMENTAL
Intervention: Sodium Tanshinone IIA Sulfonate (STS) 60 mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 42
Study: 25756440

Group type: EXPERIMENTAL
Intervention: Surgical treatment (fracture fixation or humeral head replacement)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Nonsurgical treatment (sling immobilization)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 250

Group type: COMPARATOR
Intervention: Nonsurgical treatment
Number of subjects: 250
Study: 23351488

Group type: EXPERIMENTAL
Intervention: Tidal volume of 4 ml/kg
Number of subjects: 10
Study: 21597111

Group type: EXPERIMENTAL
Intervention: High concentration oxygen (8 l/min via medium concentration mask)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Titrated oxygen (to achieve oxygen saturations between 93% and 95%)
Number of subjects: 106